4 May 2017
Ellex to Showcase Laser Floater Removal Innovations at ASCRS 2017
May 4, 2017 – Adelaide, Australia. Ellex Medical Lasers Ltd will showcase its newly launched Tango Reflex™ selective laser trabeculoplasty (SLT)/YAG laser alongside its other world-leading Laser Floater Removal (LFR) innovations at this year’s Congress of the American Society of Cataract and Refractive Surgery (ASCRS) on 5-9 May 2017 at the Los Angeles Convention Center in California, USA.
The unique LFR product portfolio includes the Ultra Q Reflex™ – the world’s first and only YAG laser optimized for anterior and posterior YAG treatments – and the new Tango Reflex™ SLT/YAG multi-modality laser – a breakthrough in laser technology that provides surgeons with four treatment modalities (SLT, LFR, capsulotomy and iridotomy) in a single device.
Reflex Technology Features
The Tango Reflex™ and the Ultra Q Reflex™ systems both utilize Ellex’s Reflex Technology™ laser platform, featuring innovations, such as titratable axis illumination and coaxial visualization, which facilitate safe, precise and effective targeting and vaporization of floaters.
Reflex Technology™ aligns the operator’s vision, the target illumination, and the treatment beam along the same optical path and the same optical plane, allowing physicians to focus on-axis with more depth and spatial reference when treating posterior floaters.
The Floater Burden
Around 30 percent of the general population have symptomatic floaters that significantly impair their vision,1 yet the majority are usually advised to tolerate their symptoms because the unacceptably high energy levels, poor beam precision and insufficient vitreous visualization associated with conventional YAG lasers makes LFR a high-risk option. However, next-generation laser technologies, such as the Tango Reflex™ and Ultra Q Reflex™, and are now making LFR a safe and effective treatment option for patients with symptomatic floaters.
Paul Singh, MD, a leading ophthalmologist from Eye Centers of Racine and Kenosha in Wisconsin, USA, has performed LFR on more than 1800 patients, with study findings revealing a 93 percent satisfaction rate among his patients after LFR. Writing about his experience with the Tango Reflex in Ophthalmology Times magazine, he said: “It’s an exciting time because for so long floaters have been ignored…and it is one of the most common patient complaints I see in my office.”
Dr Singh will be sharing his experiences with the Tango Reflex™ and of LFR at a “Speaker Central” event on Saturday 6 and Sunday 7 May from 11:30am to 12:00pm, and at a “Meet the Expert” session at the Ellex Exhibit (#2039) from 12:00pm to 12:30pm on both days.
He’ll be joined by Dr Karl Stonecipher on Saturday 6 May at the Los Angeles Convention Center (level 2, room 404 AB), to speak at the Ellex Laser Floater Removal Breakfast Symposium (hosted by Eyeworld), which will be moderated by world-renowned ophthalmologist Dr David Lubeck.
Congress attendees can also see the Tango Reflex™ and Ultra Q Reflex™ in action throughout the congress at the Ellex Exhibit #2039.
- Webb BF, Webb JR, Schroeder MC, North CS. Prevalence of vitreous floaters in a community sample of smartphone users. Int J Ophthalmol. 2013; 6(3): 402–405.
Ellex designs, develops, manufactures and sells innovative products that help eye surgeons around the world to effectively and efficiently treat eye disease. Ellex is a world leader in this field. Headquartered in Adelaide, Australia, Ellex has ophthalmic lasers and devices that treat glaucoma, retinal disease primarily caused by diabetes, secondary cataract and vitreous opacities, as well as age-related macular degeneration. Manufacturing is carried out in Adelaide, Australia and Fremont, California. Sales and service directly to eye surgeons is conducted via subsidiary offices in Minneapolis, Lyon, Berlin and Tokyo. A network of more than 50 distribution partners around the world services other markets.
For additional information about Ellex and its products, please visit www.ellex.com